Professor Elizabeth Hartland announced as new Director and CEO of Hudson

Professor Elizabeth Hartland

Professor Elizabeth Hartland will become the new Director and CEO of Hudson Institute of Medical Research, commencing August 2017.

With a long-standing interest in the pathogenesis of infections caused by E. coli and Legionella, Professor Hartland’s research focusses on mechanisms of bacterial colonisation and immune evasion.

Professor Hartland obtained her BSc (Hons) majoring in Microbiology and Biochemistry and subsequently her PhD in Microbiology from the University of Melbourne.  Until recently she was Acting Pro-Vice Chancellor Research Partnerships and External Relations, University of Melbourne. She has held a Royal Society/NHMRC Howard Florey Fellowship at Imperial College London, academic positions in the Department of Microbiology, Monash University and an Australian Research Council Future Fellowship at the University of Melbourne.

Her leadership positions at Melbourne University include Chair of the Department of Microbiology and Deputy Director Peter Doherty Institute for Infection and Immunity.

Professor Hartland said she is very excited to be moving to the Hudson Institute and honoured to be joining as the Director.

“Part of the appeal of this move is the stellar reputation of the Hudson for discovery science and translational research, including in my own area of host response to infection,” Professor Hartland said.

“I think the opportunities for the Institute are immense through close partnerships with one of Australia’s largest healthcare networks, Monash Health, and Monash University, which is well recognised as one of Australia’s highest performing universities in medical research.”

“As part of the MHTP, the Hudson is a relatively new Institute with a mission to advance science through fundamental research and to translate that research into better treatments for important human diseases.”

“I’m looking forward to helping Hudson researchers fulfil the potential and impact of their research through building the Institute’s profile and reputation globally as well as working to maximise research funding opportunities and translational partnerships,” Professor Hartland said.

Professor Hartland assumes the position from Professor Bryan Williams. Professor Williams has led the Institute since 2006, when he was appointed Director of Monash Institute of Medical Research (MIMR), and continued in this role through the merger process of MIMR with Prince Henry’s Institute, which resulted in the formation of Hudson Institute in 2014.